CASI Pharmaceuticals, Inc. (CASIF)

CASI Pharmaceuticals Revenue

In the year 2025, CASI Pharmaceuticals had annual revenue of $20.71M, down -27.42%. CASI Pharmaceuticals had revenue of $7.22M in the quarter ending December 31, 2025, a decrease of -45.93%.

• Revenue: 20.71M
• Revenue Growth: -27.42%
• P/S Ratio: 0.13
• Revenue / Employee: 96.79K
• Employees: 214
• Market Cap: 2.67M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	20.71M	-7.83M	-27.42%
Dec 31, 2024	28.54M	-5.34M	-15.77%
Dec 31, 2023	33.88M	-9.23M	-21.41%
Dec 31, 2022	43.11M	12.94M	42.89%
Dec 31, 2021	30.17M	15.03M	99.25%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error